ArticleFrontiers in aging neuroscience2025
Modeling heterogeneity in cognitive trajectories in the Framingham Heart Study.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The importance of modifiable lifestyle factors for episodic memory: a gradient boosted tree analysis.The journals of gerontology. Series B, Psychological sciences and social sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Introduction: The prevalence of cognitive impairment in the population is growing; however, there is substantial heterogeneity in the rate of decline across different cognitive domains. Harmonized factor scores measuring memory, executive function, and language domains have been created in the Framingham Heart Study (FHS). Methods: This work identified FHS participants with two or more repeated factor scores after age 60 and fitted latent class mixed models (LCMM) to cluster cognitive trajectories within each domain. Non-linear shapes of trajectories were modeled piecewise linearly, followed by stepwise selections to select cluster-specific change points. Results: We identified different latent classes of participants with early cognitive decline, compared to late decliners, for each domain. Ten-fold cross-validation yielded stable subgroupings. Our findings show latent-class-related differential patterns in cognitive aging in the FHS. We also investigated the association between identified latent classes with existing protein biomarkers of cognitive aging in a subsample of the study and found elevated levels of CD40L and CD14 were associated with a higher risk of early decline in memory and executive function domain, respectively. Discussion: In summary, our study advances the understanding of cognitive decline heterogeneity among FHS participants and sets the stage for further investigations into early intervention strategies and personalized approaches to mitigate cognitive aging risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.